Anal Cancer

Oncology
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
1 program
Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With MenN/A1 trial
Active Trials
NCT00501306Completed195Est. May 2008
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
special tampon with a diameter of 28mmN/A1 trial
Active Trials
NCT04094454Recruiting60Est. Apr 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Heidelberg Pharmaspecial tampon with a diameter of 28mm
Merck & Co.Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men

Clinical Trials (2)

Total enrollment: 255 patients across 2 trials

NCT04094454Heidelberg Pharmaspecial tampon with a diameter of 28mm

Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy

Start: Oct 2019Est. completion: Apr 202760 patients
N/ARecruiting
NCT00501306Merck & Co.Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men

Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men

Start: Jun 2007Est. completion: May 2008195 patients
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 255 patients
2 companies competing in this space